- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Collplant Biotechnologies Ltd (CLGN)
Collplant Biotechnologies Ltd stock price live, this page displays NASDAQ CLGN stock exchange data. View the CLGN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Collplant Biotechnologies Ltd real time stock price chart below.
What Is the Collplant Biotechnologies Ltd Stock Price Today?
The Collplant Biotechnologies Ltd stock price today is 1.40.
What Is the Stock Symbol for Collplant Biotechnologies Ltd?
The stock symbol for Collplant Biotechnologies Ltd is "CLGN."
What Stock Exchange Does Collplant Biotechnologies Ltd Trade On?
Collplant Biotechnologies Ltd is listed and trades on the NASDAQ stock exchange.
Is Collplant Biotechnologies Ltd a Good Stock to Buy?
Determining whether Collplant Biotechnologies Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CLGN quote. (ISIN: IL0004960188)
What Is the Collplant Biotechnologies Ltd Stock Price Today?
The Collplant Biotechnologies Ltd stock price today is 1.40.
What Is the Stock Symbol for Collplant Biotechnologies Ltd?
The stock symbol for Collplant Biotechnologies Ltd is "CLGN."
What Stock Exchange Does Collplant Biotechnologies Ltd Trade On?
Collplant Biotechnologies Ltd is listed and trades on the NASDAQ stock exchange.
Is Collplant Biotechnologies Ltd a Good Stock to Buy?
Determining whether Collplant Biotechnologies Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CLGN quote. (ISIN: IL0004960188)
NASDAQ
Currency in USD
1.40
+0.05(+3.70%)
Closed·
After Hours
1.36-0.04(-2.86%)
·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.37
1.42
52 wk Range
1.31
5.45
CLGN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
CLGN is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.371.42
52 wk Range
1.315.45
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CLGN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
12.00
Upside
+757.14%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Collplant ADR Company Profile
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. The company’s products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. It offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; VergenixSTR, a soft tissue matrix for the treatment of tendinopathy; and VergenixFG, a wound healing flowable gel for the treatment of chronic and acute wounds. The company also provides rhcollagen-based commercial bioink for regenerative medicine applications, such as Collink.3D 50L, a bioink in powder form; Collink.3D 90, an rhCollagen-based bioink solution for use in various 3D bioprinting applications; and Collink.3D 50, an rhCollagen-based bioink product. It has collaboration agreements with AbbVie; STEMCELL; the Advanced Regenerative Manufacturing Institute; Stratasys; and RegenMed Development Organization. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
Collplant Biotechnologies Ltd Earnings Call Summary for Q4/2024
- Q4 2024 EPS of -$0.34 missed forecast of -$0.275; revenue of $164,000 fell short of $432,000 expectation
- Full-year revenue decreased to $515,000 from $11 million in 2023; net loss of $16.6 million or $1.45 per share
- Stock price declined 0.68% to $2.78, near 52-week low; analysts maintain $14 price target
- Company focuses on expanding Virgenix STR distribution in Europe and Asia; optimizing regenerative breast implants
- Cash position expected to last through Q2 2026; $2 million payment received from AbbVie in February 2025
Last Updated: 26-03-2025, 08:20 pm
Read Full TranscriptCompare CLGN to Peers and Sector
Metrics to compare | CLGN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCLGNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.3x | −6.7x | −0.5x | |
PEG Ratio | 0.02 | −0.05 | 0.00 | |
Price/Book | 1.4x | 3.1x | 2.6x | |
Price / LTM Sales | 7.2x | 6.7x | 3.1x | |
Upside (Analyst Target) | - | 461.8% | 47.8% | |
Fair Value Upside | Unlock | 17.8% | 6.9% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 12.00
(+757.14% Upside)
Earnings
Latest Release
May 28, 2025
EPS / Forecast
0.10 / -0.37
Revenue / Forecast
2.05M / 1.77M
FAQ
What Is the Collplant ADR (CLGN) Stock Price Today?
The Collplant ADR stock price today is 1.40.
What Stock Exchange Does Collplant ADR Trade On?
Collplant ADR is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Collplant ADR?
The stock symbol for Collplant ADR is "CLGN."
What Is the Collplant ADR Market Cap?
As of today, Collplant ADR market cap is 17.80M.
What Is Collplant ADR's Earnings Per Share (TTM)?
The Collplant ADR EPS (TTM) is -1.21.
When Is the Next Collplant ADR Earnings Date?
Collplant ADR will release its next earnings report on 20 Aug 2025.
From a Technical Analysis Perspective, Is CLGN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Collplant ADR Stock Split?
Collplant ADR has split 1 times.
How Many Employees Does Collplant ADR Have?
Collplant ADR has 57 employees.
What is the current trading status of Collplant ADR (CLGN)?
As of 09 Jul 2025, Collplant ADR (CLGN) is trading at a price of 1.40, with a previous close of 1.40. The stock has fluctuated within a day range of 1.37 to 1.42, while its 52-week range spans from 1.31 to 5.45.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.